Effect of local hyperthermia on lymphangiogenic factors VEGF-C and -D in a nude mouse xenograft model of tongue squamous cell carcinoma

Oral Oncology

Volumn 46, Issue 2, 2010, Pages 111-115

  Liang, Xinhua ^a,b   Zhou, Hao ^a   Liu, Xian ^a   He, Yongwen ^c   Tang, Yaling ^a   Zhu, Guiquan ^a   Zheng, Min ^a   Yang, Jing ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Hyperthermia; Lymphangiogenic factors; Metastasis; Tongue squamous cell carcinoma; Vascular endothelial growth factor C; Vascular endothelial growth factor D

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HYPERTHERMIA, INDUCED; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TONGUE NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 74649086831     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.12.001     Document Type: Article

References (35)

1. Kademani D., Bell R.B., Bagheri S., Holmgren E., Dierks E., Potter B., et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg 63 11 (2005) 1599-1605
2. Brown A.E., and Langdon J.D. Management of oral cancer. Ann R Coll Surg Engl 77 6 (1995) 404-408
3. Kishimoto K., Sasaki A., Yoshihama Y., Mese H., Tsukamoto G., and Matsumura T. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol 39 4 (2003) 391-396
4. Zhou H., Tang Y., Liang X., Yang X., Yang J., Zhu G., et al. RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo. Int J Cancer 125 2 (2009) 453-462
5. Liang X., Yang X., Tang Y., Zhou H., Liu X., Xiao L., et al. RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells. Oral Oncol 44 12 (2008) 1172-1180
6. Tohnai I., Hayashi Y., Mitsudo K., Shigetomi T., Ueda M., and Ishigaki T. Prognostic evaluation of preoperative thermochemoradiotherapy for N(3) cervical lymph node metastases of oral cancer. Oncology 62 3 (2002) 234-240
7. Wust P., Stahl H., Dieckmann K., Scheller S., Löffel J., Riess H., et al. Local hyperthermia of N2/N3 cervical lymph node metastases: correlation of technical/thermal parameters and response. Int J Radiat Oncol Biol Phys 34 3 (1996) 635-646
8. Nagashima K., Takagi R., and Hoshina H. Effect of local hyperthermia on metastases in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 31 1 (2002) 84-89
9. Borkamo E.D., Fluge O., Mella O., Akslen L.A., Bruland O., and Dahl O. Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour. Radiother Oncol 86 3 (2008) 435-442
10. Oda M., Koga S., and Maeta M. Effects of total-body hyperthermia on metastases from experimental mouse tumors. Cancer Res 45 4 (1985) 1532-1535
11. Sawaji Y., Sato T., Takeuchi A., Hirata M., and Ito A. Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro. Br J Cancer 86 10 (2002) 1597-1603
12. Fukao H., Ikeda M., Ichikawa T., Inufusa H., Okada K., Ueshima S., et al. Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines. Clin Chim Acta 296 1-2 (2000) 17-33
13. Sawaji Y., Sato T., Seiki M., and Ito A. Heat shock-mediated transient increase in intracellular 3′,5′-cyclic AMP results in tumor specific suppression of membrane type 1-matrix metalloproteinase production and progelatinase A activation. Clin Exp Metastasis 18 2 (2000) 131-138
14. Lohela M., Bry M., Tammela T., and Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21 2 (2009) 154-165
15. Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 5317 (1997) 1423-1425
16. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 2 (2001) 192-198
17. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7 2 (2001) 186-191
18. He Y., Kozaki K., Karpanen T., Koshikawa K., Yla-Herttuala S., Takahashi T., et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94 11 (2002) 819-825
19. Krishnan J., Kirkin V., Steffen A., Hegen M., Weih D., Tomarev S., et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 63 3 (2003) 713-722
20. Hamaguchi S., Tohnai I., Ito A., Mitsudo K., Shigetomi T., Ito M., et al. Selective hyperthermia using magnetoliposomes to target cervical lymph node metastasis in a rabbit tongue tumor model. Cancer Sci 94 9 (2003) 834-839
21. Dong A.Q., Kong M.J., Ma Z.Y., Qian J.F., and Xu X.H. Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int 31 5 (2007) 500-507
22. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
23. Witte M.H., Way D.L., Witte C.L., and Bernas M. Lymphangiogenesis: mechanisms, significance and clinical implications. EXS 79 (1997) 65-112
24. Makinen T., Jussila L., Veikkola T., Karpanen T., Kettunen M.I., Pulkkanen K.J., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7 2 (2001) 199-205
25. Mandriota S.J., Jssila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20 4 (2001) 672-682
26. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15 7 (1996) 1751
27. Oh S.J., Jeltsch M.M., Birkenhäger R., McCarthy J.E., Weich H.A., Christ B., et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188 1 (1997) 96-109
28. Nikfarjam M., Muralidharan V., and Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 127 2 (2005) 208-223
29. Fajardo L.F., Egbert B., Marmor J., and Hahn G.M. Effects of hyperthermia in a malignant tumor. Cancer 45 3 (1980) 613-623
30. Kelleher D.K., Engel T., and Vaupel P.W. Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 11 2 (1995) 241-255
31. Kobayashi S., Kishimoto T., Kamata S., Otsuka M., Miyazaki M., and Ishikura H. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci 98 5 (2007) 726-733
32. Tsai P.W., Shiah S.G., Lin M.T., Wu C.W., and Kuo M.L. Up-regulation of vascular endothelial growth factor C in breast cancer cells by heregulin-beta 1. A critical role of p38/nuclear factor-kappa B signaling pathway. J Biol Chem 278 8 (2003) 5750-5759
33. Mountain D.J., Singh M., and Singh K. Downregulation of VEGF-D expression by interleukin-1beta in cardiac microvascular endothelial cells is mediated by MAPKs and PKCalpha/beta1. J Cell Physiol 215 2 (2008) 337-343
34. Zhang X., Li Y., Huang Q., Wang H., Yan B., Dewhirst M.W., et al. Increased resistance of tumor cells to hyperthermia mediated by integrin-linked kinase. Clin Cancer Res 9 3 (2003) 1155-1160
35. Stuhlmeier K.M. Short term hyperthermia prevents the activation of mitogen-activated protein kinase p38. Exp Gerontol 44 6-7 (2009) 406-412